LHC Group, Inc. (NASDAQ:LHCG)‘s stock had its “buy” rating restated by stock analysts at SunTrust Banks, Inc. in a report released on Friday. They presently have a $75.00 target price on the health services provider’s stock. SunTrust Banks, Inc.’s price objective suggests a potential upside of 4.43% from the company’s previous close.

Several other analysts have also commented on LHCG. Bank of America Corporation began coverage on shares of LHC Group in a research report on Monday, August 21st. They set a “buy” rating and a $76.00 price target on the stock. BidaskClub upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price target on the stock in a research report on Saturday, August 5th. Royal Bank Of Canada reiterated a “buy” rating and issued a $70.00 target price on shares of LHC Group in a research report on Wednesday, September 6th. Finally, Robert W. Baird reiterated a “hold” rating and issued a $63.00 target price on shares of LHC Group in a research report on Tuesday, September 12th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. LHC Group presently has an average rating of “Buy” and an average price target of $68.50.

LHC Group (NASDAQ:LHCG) opened at $71.82 on Friday. The company has a market capitalization of $1.31 billion, a P/E ratio of 32.32, a PEG ratio of 2.18 and a beta of 0.70. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.19. LHC Group has a 1-year low of $36.29 and a 1-year high of $76.14.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.09. The company had revenue of $260.20 million for the quarter, compared to analyst estimates of $254.10 million. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The firm’s revenue was up 15.1% on a year-over-year basis. During the same quarter last year, the business earned $0.52 earnings per share. equities research analysts anticipate that LHC Group will post 2.4 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “LHC Group, Inc. (LHCG) Stock Rating Reaffirmed by SunTrust Banks, Inc.” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/11/04/lhc-group-inc-lhcg-stock-rating-reaffirmed-by-suntrust-banks-inc.html.

In related news, COO Donald Dwayne Stelly sold 2,650 shares of the business’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the transaction, the chief operating officer now directly owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 14.80% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Federated Investors Inc. PA boosted its position in LHC Group by 4.2% during the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock worth $110,000 after acquiring an additional 66 shares during the last quarter. Acrospire Investment Management LLC boosted its position in LHC Group by 30.8% during the second quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock worth $115,000 after acquiring an additional 400 shares during the last quarter. Cubist Systematic Strategies LLC boosted its position in LHC Group by 758.0% during the second quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock worth $116,000 after acquiring an additional 1,516 shares during the last quarter. First Mercantile Trust Co. acquired a new position in LHC Group during the second quarter worth about $147,000. Finally, State of Alaska Department of Revenue boosted its position in LHC Group by 79.1% during the second quarter. State of Alaska Department of Revenue now owns 2,955 shares of the health services provider’s stock worth $200,000 after acquiring an additional 1,305 shares during the last quarter. Hedge funds and other institutional investors own 87.38% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.